CASSANDRA CAVANAUGH: Open Payments
NPI 1063581346 · DOVER, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,031 in 184 payments from 17 companies in 2025. Trend: 2023 $734 · 2024 $3,760 · 2025 $3,031
Food & beverage: $2,841Education: $190
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 13 | $453 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $362 |
| ABBVIE INC. | 26 | $316 |
| Galderma Laboratories, L.P. | 21 | $289 |
| PFIZER INC. | 27 | $224 |
| Regeneron Healthcare Solutions, Inc. | 8 | $215 |
| LEO Pharma Inc. | 11 | $204 |
| Novartis Pharmaceuticals Corporation | 7 | $179 |
| Lilly USA, LLC | 11 | $159 |
| E.R. Squibb & Sons, L.L.C. | 18 | $146 |
Products named: DUPIXENT, NEMLUVIO, CIBINQO, RINVOQ, ADBRY, Sotyktu, EBGLYSS, SKYRIZI.
Industry payments across NH — which companies pay providers there.
